Rona Inniss - Academia.edu (original) (raw)

Rona Inniss

Related Authors

Charalambos Tsekeris

Perdita Phillips

Elizaveta Solomonova

Celeste Snowber

Olav Eikeland

Sebastian Wiedemann

özgü gündeşlioğlu

Sandra L Faulkner

Helena Elias

Helena Elias

Faculdade de Belas Artes da Universidade de Lisboa

Vytautas Michelkevicius

Uploads

Papers by Rona Inniss

Research paper thumbnail of The impact of hospital design on patients and staff

British Journal of Nursing

Research paper thumbnail of Usefulness of Parkinson's KinetiGraph in a Parkinson's disease clinic – Survey of 82 patients

Parkinsonism & Related Disorders, 2016

Research paper thumbnail of The First Parkinson's Disease Pain Questionnaire (King's PD Pain Quest) – an interim analysis of a multicentre study of the patient's perspective

Parkinsonism & Related Disorders, 2016

Research paper thumbnail of Fatigue in Parkinson's disease and striatum dopamine transporter scan (DaTscan) uptake

Parkinsonism & Related Disorders, 2016

Research paper thumbnail of Restless legs syndrome - the under-recognised non-motor burden: a questionnaire-based cohort study

Postgraduate Medicine, 2019

Objectives: Non-motor symptoms (NMS) range from neuropsychiatric to pain and are an important but... more Objectives: Non-motor symptoms (NMS) range from neuropsychiatric to pain and are an important but underexplored feature of restless legs syndrome (RLS). There are currently no tools available which enable the holistic assessment of NMS in RLS in clinical practice. The primary aim of this study was to systematically assess NMS prevalence and burden in patients with RLS using the NMS Questionnaire (NMSQuest) validated for Parkinson's disease. Methods: Patients with idiopathic RLS according to the criteria of the international RLS study group (IRLSSG) were included. Patients underwent a physical examination and clinical interview as well as completed the NMS Questionnaire and the international restless legs syndrome study group (IRLSSG) rating scale. Results: Seventy-four patients with primary RLS were included (mean age 64.6 ± 14.4 years, 62.2% female, mean disease duration 23.5 ± 17.8 years, mean Levodopa equivalent daily dose 63.3 ± 67.4 mg). On average patients reported an IRLSSG rating scale score of 24.8 ± 8.2 (maximum 40) and NMSQuest score of 9.9 ± 5.0 (maximum 30). Patients reported a minimum of two NMS with the majority (39.2%) reporting a moderate NMS burden, followed by severe (28.4%) and very severe (17.6%) burden. The most frequent NMS were insomnia (89.2%) followed by nocturia (70.3%), feeling sad (59.5%), forgetfulness (54.1%), urgency (47.3%), feeling anxious (43.2%), unexplained pain (41.9%), difficulty concentrating (40.5%) and dizziness (40.5%). There were no significant differences in NMSQuest total scores according to disease duration and gender (p = 0.739, p = 0.849). Conclusion: In conclusion, this study is one of the first to address NMS in RLS systematically and the data underlines the need to holistically assess NMS in RLS in order to deliver true value-based healthcare for these patients.

Research paper thumbnail of Assessing the non-motor symptom burden progression in a longitudinal study of 411 Parkinson's patients, using the non-motor symptom questionnaire

Parkinsonism & Related Disorders, 2016

Research paper thumbnail of The impact of hospital design on patients and staff

British Journal of Nursing

Research paper thumbnail of Usefulness of Parkinson's KinetiGraph in a Parkinson's disease clinic – Survey of 82 patients

Parkinsonism & Related Disorders, 2016

Research paper thumbnail of The First Parkinson's Disease Pain Questionnaire (King's PD Pain Quest) – an interim analysis of a multicentre study of the patient's perspective

Parkinsonism & Related Disorders, 2016

Research paper thumbnail of Fatigue in Parkinson's disease and striatum dopamine transporter scan (DaTscan) uptake

Parkinsonism & Related Disorders, 2016

Research paper thumbnail of Restless legs syndrome - the under-recognised non-motor burden: a questionnaire-based cohort study

Postgraduate Medicine, 2019

Objectives: Non-motor symptoms (NMS) range from neuropsychiatric to pain and are an important but... more Objectives: Non-motor symptoms (NMS) range from neuropsychiatric to pain and are an important but underexplored feature of restless legs syndrome (RLS). There are currently no tools available which enable the holistic assessment of NMS in RLS in clinical practice. The primary aim of this study was to systematically assess NMS prevalence and burden in patients with RLS using the NMS Questionnaire (NMSQuest) validated for Parkinson's disease. Methods: Patients with idiopathic RLS according to the criteria of the international RLS study group (IRLSSG) were included. Patients underwent a physical examination and clinical interview as well as completed the NMS Questionnaire and the international restless legs syndrome study group (IRLSSG) rating scale. Results: Seventy-four patients with primary RLS were included (mean age 64.6 ± 14.4 years, 62.2% female, mean disease duration 23.5 ± 17.8 years, mean Levodopa equivalent daily dose 63.3 ± 67.4 mg). On average patients reported an IRLSSG rating scale score of 24.8 ± 8.2 (maximum 40) and NMSQuest score of 9.9 ± 5.0 (maximum 30). Patients reported a minimum of two NMS with the majority (39.2%) reporting a moderate NMS burden, followed by severe (28.4%) and very severe (17.6%) burden. The most frequent NMS were insomnia (89.2%) followed by nocturia (70.3%), feeling sad (59.5%), forgetfulness (54.1%), urgency (47.3%), feeling anxious (43.2%), unexplained pain (41.9%), difficulty concentrating (40.5%) and dizziness (40.5%). There were no significant differences in NMSQuest total scores according to disease duration and gender (p = 0.739, p = 0.849). Conclusion: In conclusion, this study is one of the first to address NMS in RLS systematically and the data underlines the need to holistically assess NMS in RLS in order to deliver true value-based healthcare for these patients.

Research paper thumbnail of Assessing the non-motor symptom burden progression in a longitudinal study of 411 Parkinson's patients, using the non-motor symptom questionnaire

Parkinsonism & Related Disorders, 2016

Log In